Provided by Tiger Trade Technology Pte. Ltd.

Greenwich Lifesciences Inc

16.67
+1.368.88%
Post-market: 16.63-0.0420-0.25%19:56 EDT
Volume:176.79K
Turnover:2.96M
Market Cap:244.69M
PE:-10.56
High:17.48
Open:16.16
Low:15.54
Close:15.31
52wk High:34.10
52wk Low:7.78
Shares:14.68M
Float Shares:7.65M
Volume Ratio:1.46
T/O Rate:2.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5783
EPS(LYR):-1.4302
ROE:-986.32%
ROA:-235.98%
PB:78.50
PE(LYR):-11.66

Loading ...

Greenwich Lifesciences Provides Update Regarding Form 10-K Filing

THOMSON REUTERS
·
Jun 01

Greenwich LifeSciences Provides Update Regarding Form 10-K Filing

GlobeNewswire
·
Jun 01

Vaccine Company to Be Acquired by Lilly to Advance Best-in-Class Vaccine Candidates for Epstein-Barr Virus and Other Infectious Diseases

THOMSON REUTERS
·
May 26

Greenwich Lifesciences Inc - Deal Valued at up to $1.55 Bln in Cash Including Upfront and Milestone Payments

THOMSON REUTERS
·
May 26

Greenwich Lifesciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

THOMSON REUTERS
·
May 23

Greenwich Lifesciences Inc expected to post a loss of 32 cents a share - Earnings Preview

Reuters
·
May 16

Greenwich LifeSciences says Form 10-K ‘still being audited’

TIPRANKS
·
Apr 30

Greenwich LifeSciences Provides Update Regarding Form 10-K Filing

GlobeNewswire
·
Apr 30

Top News Today/Canada: Retail Sales Improve Ahead of Expected Squeeze

Dow Jones
·
Apr 25

Greenwich Lifesciences’ FLAMINGO-01 breast cancer immunotherapy abstract accepted for ASCO poster

Reuters
·
Apr 23

Greenwich Lifesciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing

THOMSON REUTERS
·
Apr 23

Analysts Offer Insights on Healthcare Companies: Atai Beckley N.V. (ATAI) and Greenwich LifeSciences (GLSI)

TIPRANKS
·
Apr 22

BUZZ-U.S. STOCKS ON THE MOVE-Adobe, Agios, QXO

Reuters
·
Apr 20

BUZZ-U.S. STOCKS ON THE MOVE-TopBuild, MDA Space, Biogen

Reuters
·
Apr 20

BUZZ-Greenwich LifeSciences rises on breast cancer vaccine immune data

Reuters
·
Apr 20

Greenwich LifeSciences posts Phase III FLAMINGO-01 immune response data at AACR 2026

Reuters
·
Apr 20

Greenwich Lifesciences Presents Flamingo-01 Phase Iii Trial Open Label Data Published at Aacr Meeting 2026

THOMSON REUTERS
·
Apr 20

Top News Today: Stocks Climb on Hopes for More U.S.-Iran Peace Talks

Dow Jones
·
Apr 18

Greenwich LifeSciences says Phase III FLAMINGO-01 data show 70%-80% recurrence reduction

Reuters
·
Apr 14

Greenwich Lifesciences Provides Update on Financing Strategy

THOMSON REUTERS
·
Apr 14